对于低风险乳头状甲状腺癌且肿瘤>4厘米的患者，放射性碘消融是否必要？ - Suppr | 超能文献

Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?

作者信息

Rosario P W

机构信息

Santa Casa de Belo Horizonte, Minas Gerais, Brazil.

出版信息

Eur J Surg Oncol. 2017 Sep;43(9):1802-1803. doi: 10.1016/j.ejso.2017.05.025. Epub 2017 Jul 18.

DOI:10.1016/j.ejso.2017.05.025

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?对于低风险乳头状甲状腺癌且肿瘤>4厘米的患者，放射性碘消融是否必要？

Eur J Surg Oncol. 2017 Sep;43(9):1802-1803. doi: 10.1016/j.ejso.2017.05.025. Epub 2017 Jul 18.

2

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发

J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.

3

Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.对复发风险处于中等水平的甲状腺乳头状癌患者采用1.1吉贝可（30毫居里）碘-131进行甲状腺消融。

Thyroid. 2014 May;24(5):826-31. doi: 10.1089/thy.2013.0479. Epub 2014 Jan 24.

4

Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.因甲状腺乳头状癌淋巴结转移行再次手术后血清甲状腺球蛋白升高患者的¹³¹碘辅助治疗

Endocrine. 2015 May;49(1):279-82. doi: 10.1007/s12020-014-0414-8. Epub 2014 Sep 10.

5

Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation.术后低水平非刺激甲状腺球蛋白作为避免放射性碘消融的标准。

Endocr Relat Cancer. 2016 Jan;23(1):47-52. doi: 10.1530/ERC-15-0458. Epub 2015 Oct 26.

6

Low postoperative nonstimulated thyroglobulin as a criterion for the indication of low radioiodine activity in patients with papillary thyroid cancer of intermediate risk 'with higher risk features'.术后低水平非刺激甲状腺球蛋白作为具有较高风险特征的中度风险甲状腺乳头状癌患者低放射性碘活性指征的标准。

Clin Endocrinol (Oxf). 2016 Sep;85(3):453-8. doi: 10.1111/cen.13024. Epub 2016 Feb 12.

7

Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.甲状腺切除术后4周的甲状腺球蛋白检测可预测低危甲状腺乳头状癌的预后。

Clin Chem Lab Med. 2005;43(8):843-7. doi: 10.1515/CCLM.2005.142.

8

Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.述评：术后刺激甲状腺球蛋白在低危甲状腺乳头状癌放射性碘残留消融选择中的应用

Head Neck. 2010 Jun;32(6):698-9. doi: 10.1002/hed.21375.

9

Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.将术后刺激甲状腺球蛋白水平控制在 1ng/ml 以下作为一种标准，以避免放射性碘消融治疗低危型甲状腺乳头状癌患者。

Thyroid. 2012 Nov;22(11):1140-3. doi: 10.1089/thy.2012.0190. Epub 2012 Oct 10.

10

Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.视频辅助甲状腺切除术治疗甲状腺乳头状癌：随访≥10年患者的肿瘤学结局

World J Surg. 2018 Feb;42(2):402-408. doi: 10.1007/s00268-017-4392-x.

引用本文的文献

1

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.甲状腺球蛋白在分化型甲状腺癌患者术前和术后评估中的作用。

Front Endocrinol (Lausanne). 2022 Jun 2;13:872527. doi: 10.3389/fendo.2022.872527. eCollection 2022.